Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	591	419	365	526	301	158
Market Cap Growth	-5.99%	15.00%	-30.72%	74.57%	90.72%	-25.62%
Enterprise Value	463	295	220	373	181	71
PE Ratio	-	-5.75	-5.25	-5.95	-3.97	-0.96
PS Ratio	45.49	23.11	9.34	47.89	43.60	26.29
PB Ratio	5.15	3.95	2.66	3.11	2.96	2.17
P/FCF Ratio	-5.87	-4.82	-10.16	-7.70	-5.83	-2.21
P/OCF Ratio	-5.94	-4.88	-10.31	-7.79	-5.86	-2.23
EV/Sales Ratio	35.66	16.26	5.63	33.99	26.20	11.74
EV/EBITDA Ratio	-4.62	-4.16	-3.55	-5.21	-3.14	-0.43
EV/EBIT Ratio	-4.53	-4.08	-3.47	-5.09	-3.03	-0.43
EV/FCF Ratio	-4.25	-3.39	-6.13	-5.47	-3.51	-0.99
Debt / Equity Ratio	0.01	0.02	0.02	0.02	0.03	0.05
Debt / EBITDA Ratio	-0.02	-0.02	-0.04	-0.04	-0.05	-0.02
Debt / FCF Ratio	-0.02	-0.02	-0.06	-0.04	-0.06	-0.05
Quick Ratio	6.47	5.68	4.51	13.92	13.06	11.76
Current Ratio	6.70	5.87	4.60	14.32	13.39	11.99
Asset Turnover	0.08	0.11	0.18	0.07	0.06	0.04
Interest Coverage	-242.89	-157.71	-36.67	-25.69	-14.89	-77.93
Return on Equity (ROE)	-62.70%	-57.80%	-46.20%	-68.70%	-89.80%	-131.40%
Return on Assets (ROA)	-47.20%	-43.40%	-32.60%	-54.20%	-64.80%	-105.60%
Return on Capital (ROIC)	-68.84%	-72.40%	-45.47%	-41.64%	-54.63%	-189.32%
Earnings Yield	-12.59%	-17.38%	-19.05%	-16.80%	-25.17%	-104.32%
FCF Yield	-13.36%	-20.73%	-9.84%	-12.99%	-17.14%	-45.29%
Buyback Yield / Dilution	-8.65%	-9.95%	-42.07%	-40.10%	-32.83%	-3.24%
Total Shareholder Return	-8.65%	-9.95%	-42.07%	-40.10%	-32.83%	-3.24%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).